Clean Screen® DAU Medium Cartridge 600mg
$331.00Utilizes both a reverse (C8) phase and an ion exchange (benzenesulfonic acid) phase bonded to the same particle.
Quantity: 50/PK
Showing 41–80 of 118 results

Utilizes both a reverse (C8) phase and an ion exchange (benzenesulfonic acid) phase bonded to the same particle.
Quantity: 50/PK

Utilizes both a reverse (C8) phase and an ion exchange (benzenesulfonic acid) phase bonded to the same particle.
Quantity: 50/PK

Utilizes both a reverse (C8) phase and an ion exchange (benzenesulfonic acid) phase bonded to the same particle.
Quantity: 100/PK

Utilizes both a reverse (C8) phase and an ion exchange (benzenesulfonic acid) phase bonded to the same particle.
Quantity: 50/PK

Utilizes both a reverse (C8) phase and an ion exchange (benzenesulfonic acid) phase bonded to the same particle.
Quantity: 50/PK

Utilizes both a reverse (C8) phase and an ion exchange (benzenesulfonic acid) phase bonded to the same particle.
Quantity: 50/PK

Utilizes both a reverse (C8) phase and an ion exchange (benzenesulfonic acid) phase bonded to the same particle.
Quantity: 50/PK

Utilizes both a reverse (C8) phase and an ion exchange (benzenesulfonic acid) phase bonded to the same particle.
Quantity: 50/PK

Utilizes both a reverse (C8) phase and an ion exchange (benzenesulfonic acid) phase bonded to the same particle.
Quantity: 50/PK

Utilizes both a reverse (C8) phase and an ion exchange (benzenesulfonic acid) phase bonded to the same particle.
Quantity: 50/PK

Designed for the extraction of ethyl-glucuronide from urine.
Quantity: 50/PK

Designed for the extraction of ethyl-glucuronide from urine.
Quantity: 50/PK

Designed for the extraction of ethyl-glucuronide from urine.
Quantity: 50/PK

Employs a filtration process for quick preparation of urine samples for LC/MS analysis. The methodology eliminates the need for centrifugation, mitigates matrix suppression effects, and removes particulates larger than 1 μm. The standard FASt® sorbent is tailored for extracting drugs from urine.
Quantity: 50/PK

Employs a filtration process for quick preparation of urine samples for LC/MS analysis. The methodology eliminates the need for centrifugation, mitigates matrix suppression effects, and removes particulates larger than 1 μm. The standard FASt® sorbent is tailored for extracting drugs from urine.
Quantity: 50/PK

Employs a filtration process for quick preparation of urine samples for LC/MS analysis. The methodology eliminates the need for centrifugation, mitigates matrix suppression effects, and removes particulates larger than 1 μm. The standard FASt® sorbent is tailored for extracting drugs from urine.
Quantity: 500/PK

Employs a filtration process for quick preparation of urine samples for LC/MS analysis. The methodology eliminates the need for centrifugation, mitigates matrix suppression effects, and removes particulates larger than 1 μm. The standard FASt® sorbent is tailored for extracting drugs from urine.
Quantity: Each

Employs a filtration process for quick preparation of urine samples for LC/MS analysis. The methodology eliminates the need for centrifugation, mitigates matrix suppression effects, and removes particulates larger than 1 μm. The FASt® THC sorbent specializes in extracting the THC metabolite from urine.
Quantity: Each

Employs a filtration process for quick preparation of urine samples for LC/MS analysis. The methodology eliminates the need for centrifugation, mitigates matrix suppression effects, and removes particulates larger than 1 μm. The FASt® THC sorbent specializes in extracting the THC metabolite from urine.
Quantity: 50/PK

Employs a filtration process for quick preparation of urine samples for LC/MS analysis. The methodology eliminates the need for centrifugation, mitigates matrix suppression effects, and removes particulates larger than 1 μm. The FASt® EtG sorbent is designed for extracting EtG/EtS metabolites from urine.
Quantity: 50/PK


Employs a filtration process for quick preparation of urine samples for LC/MS analysis. The methodology eliminates the need for centrifugation, mitigates matrix suppression effects, and removes particulates larger than 1 μm. The FASt® EtG sorbent is designed for extracting EtG/EtS metabolites from urine.
Quantity: Each

Employs a filtration process for quick preparation of urine samples for LC/MS analysis. The methodology eliminates the need for centrifugation, mitigates matrix suppression effects, and removes particulates larger than 1 μm. The FASt® THC sorbent specializes in extracting the THC metabolite from urine.
Quantity: 50/PK

Patented sorbent for the isolation and extraction of free Gamma-hydroxy butyric acid (GHB).
Quantity: 50/PK

Patented sorbent for the isolation and extraction of free Gamma-hydroxy butyric acid (GHB).
Quantity: 50/PK

Patented sorbent for the isolation and extraction of free Gamma-hydroxy butyric acid (GHB).
Quantity: 50/PK

Patented sorbent for the isolation and extraction of free Gamma-hydroxy butyric acid (GHB).
Quantity: 50/PK

Utilizes both a reverse (C8) phase and an ion exchange (benzenesulfonic acid) phase bonded to the same particle.
Quantity: 50/PK

Utilizes both a reverse (C8) phase and an ion exchange (benzenesulfonic acid) phase bonded to the same particle.
Quantity: 50/PK

Utilizes both a reverse (C8) phase and an ion exchange (benzenesulfonic acid) phase bonded to the same particle.
Quantity: 50/PK

Utilizes both a reverse (C8) phase and an ion exchange (benzenesulfonic acid) phase bonded to the same particle.
Quantity: 50/PK

Utilizes both a reverse (C8) phase and an ion exchange (benzenesulfonic acid) phase bonded to the same particle.
Quantity: 50/PK

Utilizes both a reverse (C8) phase and an ion exchange (benzenesulfonic acid) phase bonded to the same particle.
Quantity: 50/PK

Features a unique blend of hydrophobic and anion exchange functionalities, optimized for THC and its metabolites.
Quantity: 50/PK

Features a unique blend of hydrophobic and anion exchange functionalities, optimized for THC and its metabolites.
Quantity: 50/PK

Features a unique blend of hydrophobic and anion exchange functionalities, optimized for THC and its metabolites.
Quantity: 50/PK

Features a unique blend of hydrophobic and anion exchange functionalities, optimized for THC and its metabolites.
Quantity: 50/PK

Features a unique blend of hydrophobic and anion exchange functionalities, optimized for THC and its metabolites.
Quantity: Each

Features a unique blend of hydrophobic and anion exchange functionalities, optimized for THC and its metabolites.
Quantity: Each

Features a unique blend of hydrophobic and anion exchange functionalities, optimized for THC and its metabolites.
Quantity: 30/PK

Features a unique blend of hydrophobic and anion exchange functionalities, optimized for THC and its metabolites.
Quantity: 100/PK
No products in the cart.